N/A
Completed N=701
Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients
Source: ClinicalTrials.gov NCT00879411 ↗Enrolled (actual)
701
Serious AEs
0.0%
Results posted
May 2012
Primary outcomePrimary: Efficacy (Change of Systolic Blood Pressure) — 8.6 mm Hg
Summary
Practical experience report (PER) investigating the effect of Micardis® on the average 24h blood pressure of therapy-naive and therapy-experienced patients
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Efficacy (Change of Systolic Blood Pressure) |
8.6 | — |
| PRIMARY Efficacy (Change of Diastolic Blood Pressure) |
4.7 | — |
| SECONDARY Overall Tolerability Scale |
9.2 | — |
Eligibility Criteria
Inclusion criteria
- Patients who have recently been diagnosed with hypertension
- Patients whose current blood pressure treatment are inadequate and needs to be revised are suitable for inclusion.
Exclusion criteria
None (according to investigator)
Data sourced from ClinicalTrials.gov (NCT00879411). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.